Millennium Management’s Inozyme Pharma INZY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.93M | Sell |
481,799
-762,923
| -61% | -$3.05M | ﹤0.01% | 2678 |
|
|
2025
Q1 | $1.13M | Sell |
1,244,722
-637,552
| -34% | -$580K | ﹤0.01% | 2912 |
|
|
2024
Q4 | $5.21M | Buy |
1,882,274
+137,821
| +8% | +$382K | ﹤0.01% | 1974 |
|
|
2024
Q3 | $9.12M | Sell |
1,744,453
-43,494
| -2% | -$227K | ﹤0.01% | 1590 |
|
|
2024
Q2 | $7.97M | Buy |
1,787,947
+1,084,341
| +154% | +$4.84M | ﹤0.01% | 1624 |
|
|
2024
Q1 | $5.39M | Sell |
703,606
-207,859
| -23% | -$1.59M | ﹤0.01% | 1923 |
|
|
2023
Q4 | $3.88M | Sell |
911,465
-415,406
| -31% | -$1.77M | ﹤0.01% | 2056 |
|
|
2023
Q3 | $5.57M | Sell |
1,326,871
-879,287
| -40% | -$3.69M | ﹤0.01% | 1809 |
|
|
2023
Q2 | $12.3M | Buy |
2,206,158
+515,083
| +30% | +$2.87M | 0.01% | 1304 |
|
|
2023
Q1 | $9.69M | Buy |
1,691,075
+1,393,139
| +468% | +$7.98M | 0.01% | 1453 |
|
|
2022
Q4 | $313K | Buy |
297,936
+127,752
| +75% | +$134K | ﹤0.01% | 3876 |
|
|
2022
Q3 | $456K | Sell |
170,184
-2,908
| -2% | -$7.79K | ﹤0.01% | 3910 |
|
|
2022
Q2 | $826K | Buy |
+173,092
| New | +$826K | ﹤0.01% | 3565 |
|
|
2022
Q1 | – | Sell |
-19,952
| Closed | -$136K | – | 5379 |
|
|
2021
Q4 | $136K | Buy |
19,952
+8,888
| +80% | +$60.6K | ﹤0.01% | 4797 |
|
|
2021
Q3 | $128K | Sell |
11,064
-50,249
| -82% | -$581K | ﹤0.01% | 4848 |
|
|
2021
Q2 | $1.05M | Sell |
61,313
-87,892
| -59% | -$1.5M | ﹤0.01% | 3687 |
|
|
2021
Q1 | $2.95M | Buy |
+149,205
| New | +$2.95M | ﹤0.01% | 2537 |
|
|
2020
Q4 | – | Sell |
-40,164
| Closed | -$1.06K | – | 4229 |
|
|
2020
Q3 | $1.06K | Buy |
+40,164
| New | +$1.06K | ﹤0.01% | 2438 |
|